TNBC is a special subgroup of breast cancer characterized by lack of estrogen receptor alpha (ERα), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2), and it accounts for approximately 15 to 20% of breast cancer patients [1]. Here, ESR1 is linked to breast carcinoma.